Found: 14
Select item for more details and to access through your institution.
56 Impact of ACTIV-6 treatment on PROMIS-29 at 7, 14, 28, and 90 days.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta‐analysis .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.257303
- By:
- Publication type:
- Article
Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta‐analysis.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.257303
- By:
- Publication type:
- Article
Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta‐analysis.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.257303
- By:
- Publication type:
- Article
Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta-analysis.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.257303
- By:
- Publication type:
- Article
Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta-analysis.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.257303
- By:
- Publication type:
- Article
Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta-analysis.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 23, doi. 10.2967/jnumed.120.257303
- By:
- Publication type:
- Article
Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta-analysis.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.257303
- By:
- Publication type:
- Article
Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta-analysis.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.257303
- By:
- Publication type:
- Article
Assessment and comparison of fluorocholine PET and sestamibi scans in identifying parathyroid adenomas: a meta‐analysis.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.257303
- By:
- Publication type:
- Article
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 950, doi. 10.1002/onco.13923
- By:
- Publication type:
- Article
Outcomes after high-dose radiation in the management of neuroendocrine neoplasms.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0252574
- By:
- Publication type:
- Article
Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 4, p. 1, doi. 10.1111/jne.13260
- By:
- Publication type:
- Article